| 1. |
Gulyás M, Kaposi AD, Elek G, et al.Value of carcinoenmbryonic antigen (CEA) and cholesterol assays of ascetic fluid in cases of inconclusive cytology.J Clin Pathol, 2001, 54(11):831-835.
|
| 2. |
Rana SV, Babu SG, Kocchar R.Usefulness of ascetic fluid cholesterol as a marker for malignant ascites.Med Sci Monit, 2005, 11(3):136-142.
|
| 3. |
羅春麗.臨床檢驗基礎.第3版.北京:人民衛生出版社, 2004:203-204.
|
| 4. |
Almakdisi T, Massoud S, Makdisi G.Lymphomas and chylous ascites:review of the literature.Oncologist, 2005, 10(8):632-635.
|
| 5. |
Balint PV, Kane D, Sturrock RD.Case number 26:massive cholesterol crystal deposition:unusual location in rheumatoid arthritis.Arm Rheum Dis, 2003, 62(6):512.
|
| 6. |
Bothenherg ME.Eosinophilic gastrointeatinal disorders (EGID).J Allergy Clin Immunol, 2004, 113(1):11-28.
|
| 7. |
Castaldo G, Oriani G, Cimino L, et al.Total discrimination of peritoneal malignant ascites from cirrhosis and hepato-carcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.Clin Chem, 1994, 40(3):478-483.
|
| 8. |
Kahn FY.Ascites in the state of Qatar:aetiology and diagnostic value of ascitic fluid analysis.Singapore Med J, 2007, 48(5):434-439.
|
| 9. |
王繼見.門脈高壓癥發病機理的研究近況.中國普外基礎與臨床雜志, 2000, 7(4):275-276.
|
| 10. |
何遠春, 李俊, 陳振東.胸腹水膽固醇測定對良惡性病變鑒別診斷的價值.安徽醫科大學學報, 2009, 44(5):655-656.
|
| 11. |
Gerbes AL, Jungst D.Role of cholesterol determination in ascitic fluid analysis.Hepatology, 2009, 50(4):1320.
|
| 12. |
陳國平, 桂滿元.胸腹水生化指標聯合應用的臨床診斷價值探討.中外醫學研究, 2011, 9(9):35-36.
|
| 13. |
劉輝, 左芳, 胡芳.膽固醇比值對胸腹水鑒別診斷的意義.檢驗醫學與臨床, 2007, 4(6):499.
|
| 14. |
張淑艷, 王海英, 熊慧順.胸腹水與血清膽固醇聯合測定對胸腹水性質的鑒別診斷意義.臨床軍醫雜志, 2011, 39(5):907-908.
|
| 15. |
蔡根度, 呂雁群, 洪迎華, 等.膽固醇分析對良惡性腹水的診斷價值.上海醫藥檢驗雜志, 1996, 11(2):127.
|
| 16. |
盛裕芬.胸腹水/血清膽固醇比值鑒別胸腹水性質.臨床檢驗雜志, 1994, 12(3):138.
|